Skip to content
Search

Latest Stories

Unnecessary closures: PDA wants 'failing pharmacies' to be taken into 'special measures control'

The Pharmaceutical Defence Association (PDA) has urged health ministers of the UK to take a strict and necessary action against the unnecessary closures of pharmacy.

Concerned over the rising number of pharmacy closures, PDA has written an open letter to health secretary Steve Barclay; Robin Swann, health minister for Northern Ireland; Eluned Morgan, minister of health and social services for Wales; and Humza Yousaf, the Scottish health secretary.


In its letter, PDA said: “The minister of health must now ensure the regulation of poor business behaviours and be prepared to take over rogue pharmacies, however large their corporate owner may be. If patients’ access to NHS services is to be protected from the consequences of avoidable full or part-day pharmacy closures.”

The association believes it is only a matter of time before serious harm to patients’ health will be caused by the decisions of mainly large chains of pharmacies to close some of their branches for all or part of a day, instead of engaging an available pharmacist to cover their agreed opening hours.

“While a small number of unforeseen closures have always occurred from time to time in pharmacies for genuine reasons, the indiscriminate scale at which closures have now become commonplace seems to have evolved over the last 20 months.”

The PDA has also noted a rapid evolution of closures as some pharmacy owners have seemingly become emboldened as no effective action or penalties to stop the closures has been taken by government, regulators, or the NHS (the main customer that commissions and funds the community pharmacy contracts).

The PDA has concluded that to protect patients, and ensure their ongoing access to pharmaceutical care, regulators in the UK should empower the Regulation and Quality Improvement Authority (RQIA) to regulate the business behaviours of companies that operate community pharmacies, including their premises, staffing levels, safety, and treatment of patients.

It's suggested an introduction a regime of financial sanctions on any businesses that breach standards and asked to provide the NHS the ultimate option to take failing pharmacies into special measures control, where the operation of that pharmacy is taken over by NHS.

Based on the actions of those who have taken commercial decisions, regardless of the potential patient impact, to unnecessarily close their branches, the PDA believes these measures are now what is required to adequately protect patients and provide communities with access to the pharmacies they rely upon.

Pharmacy closure in Scotland

Data provided to PDA in response to Freedom of Information requests in Scotland shows that the largest pharmacy businesses closed branches for full or part of days at more than 15 times the rate of other community pharmacies.

Data from NHS health boards in Scotland show that during the first five months of 2022 (1 January – 31 May) non-CCA member pharmacies reported 114 occasions across Scotland that they had to close due to unforeseen events.

“Based on the number of pharmacies owned (53 per cent non-CCA/47 per cent CCA) it would therefore be proportionate if the CCA members had reported closures due to genuine reasons on 102 full or part-day occasions during that same five-month period,” said PDA.

It added: “However, the data evidences that there were actually 1,625 reported closures of CCA member pharmacies in Scotland over that period. That means if a patients’ local pharmacy was operated by a CCA member it was more than 15 times as likely to be closed to patients for at least part of the day, than if their local pharmacy owner was a non-CCA member.”

“It is important to note that while all CCA members are headquartered in England, this data relates to Scotland only and so cannot be blamed on poor funding or previous bad policy decisions provided by NHS England. This information relates only to Scotland’s communities which are covered by the separate contract funded by Scotland’s taxpayers,” it stressed.

PDA asks information commissioner to investigate

PDA has referred NHS England to Information Commissioner over failure to share data on community pharmacy closures.

It said: “NHS England and Improvement has not been forthcoming with information requested under Freedom of Information (FOI) laws about Community Pharmacy closures, resulting in the PDA asking the Information Commissioner’s Office (ICO) to investigate.”

The PDA believe that not only does the practice of closure represent significant risk of patient harm, but it damages the reputation of pharmacy, undermines the chances of higher priority funding from governments, and discourages new entrants to the profession/existing practitioners from choosing to work in the sector.

As part of campaigning work undertaken by the PDA against unnecessary full or part-day pharmacy closure, data was requested from the NHS under the powers within the FOI Act about a range of issues including reported pharmacy closures. The association received data from each of the NHS health boards in Scotland.

“This level of information can only be identified by having the official data, and when one health board initially refused to release the information, an appeal by the PDA to the Scottish data commissioner resulted in an instruction to the health board that they must make a full disclosure as requested. Similarly, the PDA asks NHS England to share their data of reported closures as a matter of public interest,” said PDA.

It continued: “Across the UK, it is the NHS which funds the community pharmacy contracts and as it is a requirement of the NHS terms of service for community pharmacies to report each time that closures occur. Therefore many may have the reasonable expectation that the NHS would be monitoring this critical data already, as a key indicator of how their contract was being delivered.”

PDA added: "Despite multiple requests, NHS England has failed to provide the data, and therefore the PDA has been unable to carry out detailed analysis of this concerning situation to the level which has been possible for Scotland. As is appropriate when a public body fails to adequately respond to a Freedom of Information request, the PDA has escalated the matter to the Information Commissioner to investigate."

The association still hopes that NHSE will provide the data as soon as possible, hopefully before the ICO has to investigate, however if that fails to happen it will be for the ICO to determine what happens next.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less